CSI Market
Sign In | Register

Biolase Inc (BIOL) Annual Income Statement

Annual · GAAP · USD millions
Access BIOL quarterly income statements →
Quarterly income statement trends provide context on Biolase Inc's margins, operating leverage, and earnings trajectory.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
2023 		(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax49.16
Total Revenue48.72
Costs & Expenses
Cost of Goods and Services Sold32.00
Gross Profit16.72
Selling, Administration, Marketing18.44
Research and Development Expense6.00
(Gain) Loss Related to Litigation Settlement0.00
Other Operating Expense / -Income10.22
Total operating costs including COS66.66
Operating income / -loss-17.94
Interest Expense2.36
Net Interest Expense / -Income2.36
Extinguishment of Debt0.00
Other Nonoperating Gains (Losses)0.05
Foreign Currency Transaction Gain (Loss), before Tax0.35
Other loss / -income-0.10
Total costs & expenses69.33
Income & Taxes
Income / -loss before income taxes-20.60
Income taxes expenses / -benefit0.03
Income after income taxes-37.62
Net income / -loss of other equity-16.99
Income / -loss from continuing operations-37.62
Preferred dividends0.00
Net income / -loss-37.62
Income / -loss to shareholder-37.62
EBIT-18.24
EBITD-15.44
EBITDA-15.02
Earnings Per Share
Basic EPS (excl. extra items)-29.44
Extraordinary items0.00
Basic Net EPS-29.44
Basic shares outstanding (Mill. of Units)1.28
Diluted Net EPS-29.44
Diluted average shares (Mill. of Units)1.28
4 historic quarters locked

Sign in to unlock the full Biolase Inc income statement history.

Sign In Create Free Account

About Biolase Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: March 21, 2024
  • Original filing: biol-20231231.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.